After confirming the inhibition and overexpression of miR-129-5p in DLBCL cells via qRT-PCR (Figure 3D), ARID3A was found to be downregulated in miR-129-5p-overexpressing SU-DHL-2 cells and upregulated in miR-129-5p -knockdown DB and SU-DHL-6 cells (Figure 3E). This evidence concerns the gene ARID3A and diffuse large B-cell lymphoma.